NYU Lung Cancer Biomarker Center

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

RATIONALE: Screening tests that use biomarkers may help doctors find tumor cells early and plan effective treatment for lung cancer. PURPOSE: This clinical trial is studying biomarkers in screening participants for lung cancer.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: t
View:

⁃ DISEASE CHARACTERISTICS:

• Screening Cohort

‣ At high- or low-risk for lung cancer

⁃ Smoking history ≥ 20 pack years\*

• With or without workplace exposure to asbestos

• NOTE: \* Participants with \< 20 pack years of smoking are eligible if 50 years of age or older

• Rule-Out Lung cancer group

‣ Referred for evaluation of suspicious nodules with 1 of the following diagnoses:

• Lung cancer

∙ Nonmalignant nodules (control group)

⁃ PATIENT CHARACTERISTICS:

• Not pregnant

• No prior malignancy except nonmelanoma skin cancer

⁃ PRIOR CONCURRENT THERAPY:

• Not specified

Locations
United States
New York
NYU Cancer Institute at New York University Medical Center
RECRUITING
New York
Contact Information
Primary
James J. Tsay, MD, MSc
Jun-Chieh.Tsay@nyulangone.org
212-598-6351
Backup
Rosemary M Schluger
rosemary.schluger@nyulangone.org
212-263-0255
Time Frame
Start Date: 2000-05
Estimated Completion Date: 2030-05
Participants
Target number of participants: 10850
Treatments
lung cancer screening cohort
observational only. no intervention. current, former and never smokers over age 50 without history of cancer, except for non melanoma skin cancer, no previous treatment with chemotherapy.
r/o lung cancer
observational only. no intervention. patients with CT findings suspicious for lung cancer who are undergoing bronchoscopy and/or surgery.
Authors
James N. Tsay, William N. Rom
Sponsors
Leads: NYU Langone Health

This content was sourced from clinicaltrials.gov